(PharmaNewsWire.Com, August 15, 2020 ) According to a new market research report "Microplate Systems Market, by Product (Microplate Reader (Multi-mode {Hybrid}, Single-mode), Dispenser, Software), Application (Research, Clinical Diagnostics) & End User (Biotechnology, Pharmaceutical, Hospital, Diagnostic Labs) - Forecast to 2022", the global market is expected to reach USD 996.9 million by 2022 from USD 820.3 million in 2017, at a CAGR of 4.0%.
Browse 84 market data Tables and 34 Figures spread through 134 Pages and in-depth TOC of the "Microplate Systems Market".
The growth of this market is mainly driven by factors such as the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases.
The Microplate Readers Segment:
Based on product, the market is segmented into microplate readers, microplate pipetting systems and dispensers, microplate washers, and other products. In 2017, microplate readers segment is expected to account for the largest share of the microplate systems market as it is used in various applications such as investigation of new drug targets in the early stages of drug discovery as well as in research, bioassay validation, QC, and for the detection of biological, chemical, or physical processes in samples contained in microtiter plates.
Based on type, microplate readers market is segmented into multi-mode microplate reader and single-mode microplate reader. The multi-mode microplate readers are expected to dominate the market in 2017. It is also expected to register the highest growth rate during the forecast period. The growth of this segment is attributed to the advantages associated with it such as increased throughput and efficiency.
Drug Discovery Segment:
Based on application, the market is segmented into drug discovery, clinical diagnostics, genomics and proteomics research, and other applications (cell biology, food testing, and environmental monitoring). The drug discovery segment is estimated to hold the largest share of the microplate systems market in 2017. It is expected to register the highest CAGR during the forecast period. The need for high-/ultra-high-throughput screening and reduced time-to-market for drugs are the major drivers for the growth of the drug discovery segment.
North America and Europe to Dominate The Industry:
North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to increasing government investments to support the development of advanced diagnostic procedures, technological advancements, increasing ageing population, easy accessibility and high adoption of advanced research and diagnostic technologies (due to the significant per capita annual healthcare expenditure by the government) and rising prevalence of chronic and infectious diseases. In 2017, Europe is expected to account for the second-largest share of this market. Rising government support for research and innovation and expanding biotechnology industry are the major factors supporting the growth of the microplate systems market in this regional segment.
The microplate systems market is highly competitive with the presence of several big and small players. In 2016, Tecan (Switzerland), Bio-Rad (US), Thermo Fisher (US), Danaher (US), and PerkinElmer (US) were the leading players in the microplate systems market. Other major players include BioTek (UK), BMG LABTECH (Germany), BERTHOLD (Germany), Agilent (US), Promega (US), Biochrom (UK), Corning (US), Lonza (Switzerland), Rayto (China), and Mindray (China).
Tecan (Switzerland) was one of the leading players in the microplate systems market. This leading position of the company can be attributed to its strong brand recognition. It has a strong presence in North America, Europe, and Asia. In order to maintain its leading position in the microplate systems market, the company focuses on research and development activities. The company invested USD 47.1 million, USD 39.9 million, and USD 39.5 million in R&D activities in 2014, 2015, and 2016, respectively. The company also focuses on inorganic and organic growth strategies like product launches, expansions, agreements, acquisitions, and collaborations to gain a competitive edge.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
